Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -37.64% is 49% below its 5-year average of -25.21%, near the low end of its 5-year range (-37.64%–-1.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.74% below its 12-month average of -33.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -37.64%.
RETURN ON INVESTED CAPITAL (ROIC)
-37.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-33.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-30.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-25.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.74%
CURRENT VS 3Y AVG
-23.36%
CURRENT VS 5Y AVG
-49.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-5.60%
vs the sector median at left
Treace Medical Concepts, Inc.
Market Cap
$264.68M
Return on Invested Capital (ROIC)
-37.64%
TTM Avg
-33.68%
3Y Avg
-30.51%
5Y Avg
-25.21%
Market Cap
$264.25M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$263.97M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$266.00M
Return on Invested Capital (ROIC)
-59.50%
TTM Avg
-188.11%
3Y Avg
-308.62%
5Y Avg
-250.56%
Market Cap
$267.50M
Return on Invested Capital (ROIC)
-58.72%
TTM Avg
-52.25%
3Y Avg
-49.23%
5Y Avg
-41.07%
Market Cap
$260.94M
Return on Invested Capital (ROIC)
-15.00%
TTM Avg
-11.69%
3Y Avg
-3.29%
5Y Avg
-2.92%
Market Cap
$261.24M
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-103.16%
3Y Avg
-110.30%
5Y Avg
-171.09%
Market Cap
$262.00M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$268.81M
Return on Invested Capital (ROIC)
-74.73%
TTM Avg
-25.64%
3Y Avg
-13.00%
5Y Avg
-6.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $264.68M | -37.64% | -33.68% | -30.51% | -25.21% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.97M | -42.92% | -30.10% | -80.25% | -64.52% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $266.00M | -59.50% | -188.11% | -308.62% | -250.56% |
| Fate Therapeutics, Inc. (FATE)vs › | $267.50M | -58.72% | -52.25% | -49.23% | -41.07% |
| OraSure Technologies, Inc. (OSUR)vs › | $260.94M | -15.00% | -11.69% | -3.29% | -2.92% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | -28.96% | -103.16% | -110.30% | -171.09% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | -170.19% | -56.97% | -50.85% | -45.83% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $268.81M | -74.73% | -25.64% | -13.00% | -6.89% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $269.18M | -31.62% | -73.81% | -69.44% | -42.80% |
ROIC
-37.6%
ROE
-87.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -37.64% |
| 2026-03-31 | -37.26% |
| 2025-12-31 | -33.86% |
| 2025-09-30 | -30.76% |
| 2025-06-30 | -28.91% |
| 2025-03-31 | -30.28% |
| 2024-12-31 | -30.57% |
| 2024-09-30 | -35.65% |
| 2024-06-30 | -35.76% |
| 2024-03-31 | -28.94% |
| 2023-12-31 | -24.86% |
| 2023-09-30 | -23.23% |
| 2023-06-30 | -18.96% |
| 2023-03-31 | -17.94% |
| 2022-12-31 | -27.06% |
| 2022-09-30 | -27.60% |
| 2022-06-30 | -21.88% |
| 2022-03-31 | -17.69% |
| 2021-12-31 | -13.47% |
| 2021-09-30 | -5.74% |
| 2021-06-30 | -1.42% |
| 2021-03-31 | 2.26% |
| 2020-12-31 | 2.67% |
